Kunnskapsgrunnlag for medikamentell behandling
En oversikt over alle publikasjoner som er brukt i vurderingene knyttet til medikamentell behandling i Tiltakshåndboka.
Amerio (2021): Polypharmacy as maintenance treatment in bipolar illness: A systematic review
Becker (2021): Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review
Jardim (2021): Effekt av antipsykotika ved behandling uten pasientens samtykke sammenlignet med frivillig behandling: en systematisk oversikt
Jardim (2021): Effekten av antipsykotika ved førstegangspsykose:en systematisk oversikt
LaCasse (2021): Naltrexone for adolescent opioid use disorder: a bridge in the treatment gap?
Witt (2021): Interventions for self‐harm in children and adolescents
Tsujii (2020): Effect of Continuing and Discontinuing Medications on Quality of Life After Symptomatic Remission in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis
Viswanathan (2020): Treatment of Depression in Children and Adolescents: A Systematic Review
Jochim (2019): Valproate for acute mania
McKnight (2019): Lithium for acute mania
Molyneaux (2018): Update: Antidepressants for preventing postnatal depression
NICE (2018): Post-traumatic stress disorder. E: Post-traumatic stress disorder. Evidence reviews for pharmacological interventions for the prevention and treatment of PTSD in children (NG116)
NICE (2018): Attention deficit hyperactivity disorder: diagnosis and management (NG87)
NICE (2018): Post-traumatic stress disorder. B: Evidence reviews for psychological, psychosocial and other non-pharmacological interventions for the treatment of PTSD in children and young people (NG116)
Sundhedsstyrelsen (2018): Udredning og behandling af ADHD hos børn og unge: National klinisk retningslinje.
Xia (2018): Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials
Atkin (2017): Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder
NICE (2017): Eating Disorders: Recognition and treatment (NG69)
Wang (2017): Anxiety in Children
Matsui (2016): Azapirones for attention deficit hyperactivity disorder: A systematic review
Ost (2016): Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis
Sundhedsstyrelsen (2016): National klinisk retningslinje for behandling av obsessiv-kompulsiv tilstand (OCD)
Hawton (2015): Interventions for self-harm in children and adolescents
Maynard (2015): Psychosocial Interventions for School Refusal with Primary and Secondary School Students: A Systematic Review
NICE (2015): Psychosis and schizophrenia in children and young people. Evidence update (CG155)
Ougrin (2015): Therapeutic Interventions for Suicide Attempts and Self-Harm in Adolescents: Systematic Review and Meta-Analysis
Diaz-Caneja (2014): Practitioner review: Long-term pharmacological treatment of pediatric bipolar disorder
Maneeton (2014): A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
Minozzi (2014): Detoxification treatments for opiate dependent adolescents
NICE (2014): Bipolar disorder: assessment and management (CG185)
NICE (2014): Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings. Evidence update (CG120)
Sundhedsstyrelsen (2014): National klinisk retningslinje for utredning og behandling av ADHD hos børn og unge
Suttajit (2014): Quetiapine for acute bipolar depression: a systematic review and meta-analysis
Kumar (2013): Atypical antipsychotics for psychosis in adolescents
Punja (2013): Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy
Chiesa (2012): Quetiapine for bipolar depression: A systematic review and meta-analysis
NICE (2011): Self-harm in over 8s: Long-term management (CG133)
NICE (2004): Self-harm: The short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care (CG16)